{"disease":{"id":"renal-impairment","name":"renal impairment"},"drugs":{"marketed":[{"drug_id":"amifostine","indication_name":"Prevention of Cancer Chemotherapy-Induced Renal Impairment","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ethyol","generic_name":"AMIFOSTINE","company_name":"Cosette","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"amifostine","quality_score":75,"revenue":null,"mechanism":"Ethyol works by protecting the kidneys and salivary glands from damage caused by chemotherapy and radiation."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05006001","title":"Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"En Chu Kong Hospital","has_results":false},{"nct_id":"NCT03767803","title":"Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women","phase":"","overall_status":"UNKNOWN","enrollment_count":344,"lead_sponsor_name":"Progenity, Inc.","has_results":false},{"nct_id":"NCT00948116","title":"Development of a Biomarker Panel for the Earlier Prediction of Acute Kidney Injury in Patients With Diabetes","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT05349851","title":"Bowel Cleansing With Renal Impairment","phase":"","overall_status":"UNKNOWN","enrollment_count":237,"lead_sponsor_name":"Marco Antonio Alvarez Gonzalez","has_results":false},{"nct_id":"NCT02596945","title":"Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis","phase":"","overall_status":"COMPLETED","enrollment_count":223,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT03483584","title":"Incidence of HANA Conditions in HIV-infected Individuals","phase":"","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":true},{"nct_id":"NCT03586531","title":"Renal Biopsy Unexplained Elevated Serum Creatinine","phase":"","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07241494","title":"Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment.","phase":"NA","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT07017933","title":"Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes","phase":"NA","overall_status":"RECRUITING","enrollment_count":124,"lead_sponsor_name":"3ive Labs","has_results":false},{"nct_id":"NCT04273230","title":"Kidney Affection in Non Alcaholic Fatty Liver Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03330054","title":"Frequency Of Eye Problems In Type 2 Diabetes With Chronic Kidney Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Mohammed Ramadan Abdallah","has_results":false},{"nct_id":"NCT01104662","title":"Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":92,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT04119843","title":"Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Ascelia Pharma AB","has_results":true},{"nct_id":"NCT05368935","title":"Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Genfit","has_results":false},{"nct_id":"NCT05731804","title":"Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":72,"lead_sponsor_name":"Jiangsu Simcere Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02207088","title":"Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT00833716","title":"Effect of Renal Impairment on the Pharmacokinetics of NN9535","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT05552859","title":"Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":62,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT03455322","title":"Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"National Hepatology & Tropical Medicine Research Institute","has_results":false},{"nct_id":"NCT05940402","title":"A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT02998775","title":"Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Eisai Inc.","has_results":false},{"nct_id":"NCT03131479","title":"Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07154901","title":"Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03904550","title":"Neuromuscular Blockade in Patients With Severe Renal Impairment","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":true},{"nct_id":"NCT05086107","title":"Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"BioVersys AG","has_results":false},{"nct_id":"NCT05099445","title":"Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT04646889","title":"Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Arthrosi Therapeutics","has_results":false},{"nct_id":"NCT06407375","title":"Assessment of Renal Function by Multiparametric MRI","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"University of Zurich","has_results":true},{"nct_id":"NCT05515432","title":"A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03890770","title":"A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT05631938","title":"Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Achieve Life Sciences","has_results":false},{"nct_id":"NCT05497297","title":"A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT06352411","title":"A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT03259087","title":"Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04616027","title":"STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06693765","title":"A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06527677","title":"Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Antabio","has_results":false},{"nct_id":"NCT07217886","title":"A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Shionogi","has_results":false},{"nct_id":"NCT06589713","title":"Effect of Renal Impairment on Enpatoran Pharmacokinetics","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","has_results":false},{"nct_id":"NCT03378271","title":"Accuracy and Treatment Experience of Two Glucose Monitoring Systems Tested in Patients With Type 1 Diabetes and Renal Impairment","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false},{"nct_id":"NCT03192111","title":"A Study to Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Syndax Pharmaceuticals","has_results":false},{"nct_id":"NCT02341599","title":"Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":true},{"nct_id":"NCT04623710","title":"Study of ALXN2050 in Participants With Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04859439","title":"A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT07076030","title":"Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Zealand Pharma","has_results":false},{"nct_id":"NCT04178577","title":"Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Spero Therapeutics","has_results":false},{"nct_id":"NCT04865393","title":"Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Spero Therapeutics","has_results":false},{"nct_id":"NCT07034768","title":"A Study to Evaluate EDG-7500 in People With Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Edgewise Therapeutics, Inc.","has_results":false},{"nct_id":"NCT01948986","title":"Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03235076","title":"Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Bayer","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}